L'Estratto Di Serenoa Repens Nel Trattamento Dei Disturbi Funzionali Secondari Ad Adenoma Della Prostata: Considerazioni Su 20 Casi

Aragona F. , Spinelli C. , Marconi A. , Arganini M. : Trattamento dell'adenoma prostatico con un'associazione di Semen Cucurbitae e di Radix Echinaceae. Valutazioni clinico-radiologiche ed urodinamiche in 20 pazienti. Farmaci, 9; 23–24 (1985).

Briley M. , Carilla E. , Fauran F. : Permixon, a new treatment for benign prostatic hyperplasia, acts directly at the cytosolic androgen receptors in rat prostate. Personal Communication. 6^th Intern. Symposium of the Journal of Steroid Biochemistry, 1984.

Carilla E. , Briley M. , Fauran F. , Sultan C. , Duvilliers C. : Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prosate. J. Steroid. Biochem., 20; 521–523 (1984).

Flamm J. , Kiesswetter H. , English M. : Urodynamische Verlhaufs Kontrolle bei konservativer Behandlung des Prostata Adenomas mit Phytopraparat und Testosteron. Wien. Klin. Wschr., 91; 622–627 (1979).

Fretin J. , Oiler C. : Le traitement medical de l'hypertrophie benigne de la prostate. Concours med., 105; 1811–1819 (1983).

Krieg M. : A comparative study of binding, metabolism and endogenous levels of androgens in normal hyperplastic and carcinomatous human prostate. J. Steroid. Biochem., 11; 615–624 (1979).

Schilcher H. : Phitopharmaka zur Therapie von Prostate Krankungen. Zeit. Angew. Phitoth., 2; 14 (1981).

Siiteri P. K. , Wilson J. D. : Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of DHT in the hypertrophic prostate of the man. J. Clin. Invest., 49; 1737–1745 (1970).

Stenger A. , Tarayre J. P. , Carilla E. , Delhon A. , Charveron M. , Morre M. , Lauressergues H. : Etude pharmacologique et biochimique de l'extrait héxanique de Serenoa repens B (PA 109). Gaz. méd de France, 89; 2041–2048 (1982).

Sultan C. , Terraza A. , Devillier C. , Carilla E. , Briley M. , Loire C. , Descomps B. : Inhibition of androgen metabolism and binding by a liposterolic extract of Serenoa repens B in human foreskin fibroblasts. J. Steroid. Biochem., 20; 515–519 (1984).

Tasca A. , Barulli M. , Cavazzana A. , Zattoni F. , Artibani W. , Pagano F. : Trattamento della sintomatologia ostruttiva da adenoma prostatico con estratto di Serenoa repens. Studio clinico in doppio cieco vs. placebo. In corso di stampa su Minerva Urologica.

Walsh P. C. : In: Benign prostatic hyperplasia. Harrison J. H. , Gittes R. F. , Perlmutttr A. D. , Stamey P. H. , Walsh P. C. (Edrs), Campbell's Urology, p. 949–966. W. B. Saunders, Philadelphia 1979.

Wilson J. D. : The pathogenesis of benign prostatic hyperplasia. Amer. J. Med., 68; 745–756 (1980).